BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 7.09.2004

Scientific Considerations Related to Developing Follow-On Protein Products; Correction

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of August 16, 2004 (69 FR 50386). The document announced a public workshop on scientific and technical considerations related to the development of follow-on protein pharmaceutical products. The document was published with an inadvertent error. This document corrects that error.

Source: Federal Register — Food and Drug AdministrationOpen original release →